Siegfried Holding
Siegfried Holding AG, commonly referred to as Siegfried, is a leading player in the pharmaceutical and chemical industry, headquartered in Zofingen, Switzerland. Established in 1873, the company has expanded its operations across Europe and North America, solidifying its presence in key markets. Siegfried specialises in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, offering unique solutions that cater to the evolving needs of the healthcare sector. With a commitment to quality and innovation, Siegfried has achieved significant milestones, including strategic acquisitions that enhance its capabilities and market reach. Recognised for its robust portfolio and expertise, Siegfried holds a strong market position, serving a diverse clientele and contributing to advancements in pharmaceutical manufacturing.
DitchCarbon Score
How does Siegfried Holding's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Siegfried Holding's score of 41 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Siegfried Holding's reported carbon emissions
In 2023, Siegfried Holding reported carbon emissions of approximately 57,688 tonnes CO2e for Scope 1 and about 10,478 tonnes CO2e for Scope 2, alongside significant Scope 3 emissions totalling around 459,700 tonnes CO2e. This reflects their ongoing commitment to sustainability within the pharmaceutical sector. Siegfried has set ambitious targets to reduce its carbon footprint by 50% by 2030, using 2020 as the baseline year. This commitment specifically focuses on Scope 1 and Scope 2 emissions, aiming for a substantial decrease in CO2 emissions normalised to sales. Furthermore, the company has pledged to achieve net-zero emissions across all scopes by 2050, aligning with industry standards for climate action. The company has made notable progress in its emissions management, with a reported reduction in Scope 1 emissions from approximately 101,100 tonnes CO2e in 2019 to about 57,688 tonnes CO2e in 2023. This demonstrates a proactive approach to mitigating climate impact and enhancing operational efficiency. Siegfried's commitment to sustainability is further evidenced by its participation in the Science Based Targets initiative (SBTi), where it has committed to long-term net-zero targets. The company continues to focus on reducing its carbon emissions while maintaining its growth trajectory in the pharmaceuticals, biotechnology, and life sciences sectors.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 16,300,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 00,000,000 | 0,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Siegfried Holding is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
